Skip to content

Autosomal Recessive Dyskeratosis Congenita 4 C3151444

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder affecting multiple body systems, including bone marrow, skin, and mucous membranes. Patients require monitoring for bone marrow failure and increased cancer risk, with supportive care from various specialists.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pancytopenia

!

Pulmonary fibrosis

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Abnormal nail morphology

(integumentary)

Reticular skin pigmentation

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Hematologic Surveillance

Regular complete blood counts and bone marrow function monitoring to detect early signs of bone marrow failure. Frequency based on disease severity and prior monitoring trends.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Growth Factor Supportive Therapy

Administration of hematopoietic growth factors such as granulocyte colony-stimulating factor when neutropenia develops. May reduce infection risk and support blood counts.

medication

Additional treatment options

Androgen Therapy for Bone Marrow Failure

Anabolic steroids such as oxymetholone may be used to support blood cell production in some patients with bone marrow failure. Response is variable and requires monitoring.

medication

Hematopoietic Stem Cell Transplantation

Curative option for eligible patients with severe bone marrow failure or MDS/leukemia transformation. Requires HLA-matched donor identification and careful pre-transplant evaluation.

surgical

Transfusion Support Therapy

Red blood cell and platelet transfusions for symptomatic anemia or thrombocytopenia when other therapies are ineffective or contraindicated. Iron chelation may be needed with chronic transfusion support.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Dyskeratosis Congenita 4 C3151444?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Savage SA, Bertuch AA. Dyskeratosis congenita: clinical and genetic advances. Blood Rev. 2020.

review2020
2

Alter BP, Brown DH, Giri N, et al. Guidelines for the diagnosis and management of telomere biology disorders. J Clin Oncol. 2022.

guideline2022
3

Dokal NS, Vulliamy TJ, Mason PJ, et al. Clinical manifestations and molecular basis of dyskeratosis congenita. Blood. 2019.

clinical_trial2019
4

Fernandez Garcia MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. Am J Hematol. 2021.

review2021

Medication Comparisons

Compare medications used to treat Autosomal Recessive Dyskeratosis Congenita 4 C3151444. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy